Publications by authors named "M Adelaida Velasquez"

Objective: To assess the association of being overweight or obese with Nonmuscle invasive bladder cancer (NMIBC) recurrence, stage progression, and grade progression.

Methods: Patients with NMIBC were included and categorized into 3 groups based on their body mass index (BMI): normal weight, overweight, and obese. Recurrence was defined as any histologically proven bladder cancer on subsequent transurethral resection of bladder tumor (TURBT).

View Article and Find Full Text PDF

Background: Screening and brief intervention (BI) can reduce risky alcohol use but has not been widely implemented in primary care settings. We sought to implement a screening and telephone-based program within a Federally Qualified Health Center (FQHC).

Design: Prior to this program, adult patients were routinely screened using AUDIT-C with no further systematic follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • * Astrocytes play a vital role in managing neuroinflammation and neuroplasticity, two processes that are important for understanding how depression develops.
  • * Research suggests that targeting the different roles of astrocytes could lead to new treatments for depression by addressing issues related to inflammation and brain adaptability.
View Article and Find Full Text PDF

Purpose: Electrocardiography (ECG) and respiratory-gated preclinical cardiac CEST-MRI acquisitions are difficult because of variable saturation recovery with T, RF interference in the ECG signal, and offset-to-offset variation in Z-magnetization and cardiac phase introduced by changes in cardiac frequency and trigger delays.

Methods: The proposed method consists of segmented saturation modules with radial FLASH readouts and golden angle progression. The segmented saturation blocks drive the system to steady-state, and because center k-space is sampled repeatedly, steady-state saturation dominates contrast during gridding and reconstruction.

View Article and Find Full Text PDF

BCL-2 protein overexpression, common in B-cell acute lymphoblastic leukemia (B-ALL), including the Philadelphia (Ph)-like subtype, mediates leukemic cell survival. We treated 24 patients with 14 days of BCL-2 inhibitor, venetoclax, 400 mg daily (dose level 1) during induction and consolidation cycles combined with the CALGB 10403 regimen in newly diagnosed adults with Ph-negative B-ALL. Median age was 31 (range: 18-53) years, 92% were Hispanic, and 12 (50%) patients had Ph-like ALL.

View Article and Find Full Text PDF